research Infliximab as First‐Line Therapy in Severe Pediatric Crohn Disease 19 citations , September 2006 in “Journal of Pediatric Gastroenterology and Nutrition” Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.
research Cutaneous Crohn's disease treated with infliximab and 4 years of follow up 9 citations , June 2013 in “Australasian Journal of Dermatology” Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.
research Alopecia areata in a patient receiving infliximab 9 citations , January 2013 in “Indian journal of dermatology, venereology, and leprology” Infliximab may cause hair loss in Crohn's disease patients.
research Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome 2 citations , November 2004 in “Hospital pharmacy” Certain medications can cause serious side effects, so it's important to report them.
research Infliximab-Associated Psoriasiform Alopecia 1 citations , October 2015 in “The American journal of gastroenterology” Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.